Ke Gui

Ke Gui

Auto-generated profile, based on publicly available information

Ke Gui

Southeast University

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2026 in Progress in Biomedical Engineering
Verified
Journal Article
Closed access
KGKe Gui
Ke Gui
QLQiong Li
Qiong Li
ZXZongyu Xie
Zongyu Xie
TZTong Zhan
Tong Zhan
XLXiaosheng Long
Xiaosheng Long
HLHongde Liu
Hongde Liu
Gliomas are heterogeneous primary central nervous system tumors with diverse molecular subtypes and variable prognosis. A paradigm shift in histopathology is underway as samples are digitized into whole-slide images (WSIs). Deep learning (DL) shows great potential for glioma diagnosis, subtyping, grading, and prognosis. This review summarizes recent advances in WSI-based DL models, covering data preprocessing, model architectures, and translational performance. Model evolution has progressed from CNNs (e.g. ResNet, capturing local features via convolution) to Transformers (e.g. Vision transformer, modeling global dependencies via self‐attention), hybrid architectures, and large language model. Typical pipelines include quality control, stain normalization, patch extraction, feature integration, and prediction. Public datasets such as The Cancer Genome Atlas and Clinical Proteomic Tumor Analysis Consortium serve as key resources. On various datasets (public and institutional), a glioma‐specific model ResNet‐50 achieved AUC 0.983 for subtype classification; a Vision Transformer model reached AUC 0.960 for molecular typing; a hybrid model, ROAM, attained AUC 0.990; and the pan‐cancer hybrid model called CHIEF achieved AUC 0.9397 for diagnosis. Attention heatmaps and Shapley Additive exPlanations provide interpretability by linking model outputs to histologic regions. Novel multimodal fusion integrates genomic, proteomic, radiologic, and clinical data to enhance prediction and uncover biological relevance. Future research may focus on enhancing model generalizability and predictive accuracy via advanced architectures, developing lightweight models for resource-limited settings to facilitate clinical translation.